Pericyazine ♣ [Propericyazine]

This chapter presents a trade name, classification, approved indications for psychological disorders, available dosage forms, storage, and compatibility, usual dosage and administration, relative contraindications, and clinically significant drug interaction of Pericyazine. Avoid prescribing pericyazine pharmacotherapy to women who are pregnant. If pericyazine pharmacotherapy is required, advise patients of potential benefits and possible risks to themselves and the embryo, fetus, or neonate. Collaboration with the patient’s obstetrician is indicated. Pericyazine is a piperidine phenothiazine related to thioridazine. It reduces pathologic arousal and affective tension among selected patients who have psychotic disorders. Caution patients who are receiving pericyazine pharmacotherapy against performing activities that require alertness, judgment, and physical coordination until their response to pericyazine is known. In addition to this general precaution, caution patients to inform their prescribing psychologist if they begin or discontinue any other pharmacotherapy while receiving pericyazine pharmacotherapy.